Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,622 | 155 | 98.2% |
| Education | $40.32 | 8 | 1.5% |
| Consulting Fee | $7.18 | 1 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $474.43 | 29 | $0 (2020) |
| Lilly USA, LLC | $389.72 | 29 | $0 (2020) |
| AstraZeneca Pharmaceuticals LP | $356.99 | 23 | $0 (2020) |
| PFIZER INC. | $308.52 | 18 | $0 (2020) |
| Janssen Pharmaceuticals, Inc | $256.39 | 12 | $0 (2020) |
| Amarin Pharma Inc. | $200.40 | 8 | $0 (2020) |
| SANOFI-AVENTIS U.S. LLC | $181.73 | 11 | $0 (2019) |
| GlaxoSmithKline, LLC. | $136.59 | 10 | $0 (2019) |
| Merck Sharp & Dohme Corporation | $92.32 | 7 | $0 (2020) |
| E.R. Squibb & Sons, L.L.C. | $62.41 | 3 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $43.65 | 2 | Abbott Laboratories ($23.87) |
| 2023 | $23.11 | 1 | NESTLE HEALTHCARE NUTRITION INC. ($23.11) |
| 2021 | $7.18 | 1 | KVK-Tech, Inc. ($7.18) |
| 2020 | $343.08 | 22 | Novo Nordisk Inc ($107.72) |
| 2019 | $815.42 | 48 | Amarin Pharma Inc. ($187.67) |
| 2018 | $698.82 | 43 | Novo Nordisk Inc ($154.90) |
| 2017 | $738.63 | 47 | Lilly USA, LLC ($147.36) |
All Payment Transactions
164 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/16/2024 | Edwards Lifesciences Corporation | SAPIEN 3 Ultra RESILIA (Device) | Food and Beverage | In-kind items and services | $19.78 | General |
| Category: Transcatheter Heart Valves | ||||||
| 06/06/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $23.87 | General |
| Category: Diabetes Care | ||||||
| 09/13/2023 | NESTLE HEALTHCARE NUTRITION INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $23.11 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 01/21/2021 | KVK-Tech, Inc. | — | Consulting Fee | Cash or cash equivalent | $7.18 | General |
| 11/08/2020 | KVK-Tech, Inc. | — | Food and Beverage | Cash or cash equivalent | $7.57 | General |
| 11/08/2020 | KVK-Tech, Inc. | — | Food and Beverage | Cash or cash equivalent | $7.57 | General |
| 11/08/2020 | KVK-Tech, Inc. | — | Food and Beverage | Cash or cash equivalent | $7.57 | General |
| 10/16/2020 | Novo Nordisk Inc | RYBELSUS (Drug), Ozempic | Food and Beverage | In-kind items and services | $15.02 | General |
| Category: Diabetes | ||||||
| 10/08/2020 | PFIZER INC. | PREVNAR 13 (Biological) | Food and Beverage | In-kind items and services | $22.89 | General |
| Category: VACCINES | ||||||
| 09/24/2020 | Lilly USA, LLC | TRULICITY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $12.04 | General |
| Category: Diabetes | ||||||
| 09/17/2020 | Merck Sharp & Dohme Corporation | PNEUMOVAX 23 (Biological), VAQTA, GARDASIL 9 | Food and Beverage | In-kind items and services | $12.66 | General |
| Category: VACCINE | ||||||
| 09/10/2020 | PFIZER INC. | PREVNAR 13 (Biological) | Food and Beverage | In-kind items and services | $17.05 | General |
| Category: VACCINES | ||||||
| 08/26/2020 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $12.79 | General |
| Category: Diabetes | ||||||
| 08/20/2020 | Lilly USA, LLC | EMGALITY (Drug), REYVOW | Food and Beverage | In-kind items and services | $16.21 | General |
| Category: Neuroscience | ||||||
| 08/13/2020 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $15.64 | General |
| Category: Diabetes | ||||||
| 07/30/2020 | Lilly USA, LLC | TRULICITY (Drug) | Food and Beverage | In-kind items and services | $19.56 | General |
| Category: Diabetes | ||||||
| 07/23/2020 | AstraZeneca Pharmaceuticals LP | SYMBICORT (Drug) | Food and Beverage | In-kind items and services | $14.22 | General |
| Category: Respiratory | ||||||
| 06/25/2020 | PFIZER INC. | CHANTIX (Drug), EUCRISA, COLOGUARD | Food and Beverage | In-kind items and services | $13.94 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 06/18/2020 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $16.24 | General |
| Category: Diabetes | ||||||
| 06/11/2020 | Lilly USA, LLC | SYNJARDY (Drug), TRULICITY, JARDIANCE | Food and Beverage | In-kind items and services | $11.46 | General |
| Category: Diabetes | ||||||
| 06/04/2020 | PFIZER INC. | TOVIAZ (Drug), CHANTIX, COLOGUARD | Food and Beverage | In-kind items and services | $14.25 | General |
| Category: GENITOURINARY (UROLOGY) | ||||||
| 05/21/2020 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $30.14 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 05/14/2020 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.50 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/12/2020 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $33.58 | General |
| Category: Diabetes | ||||||
| 05/11/2020 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $12.73 | General |
| Category: Cardiovascular | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 18 | 1,276 | 1,485 | $225,972 | $117,394 |
| 2022 | 14 | 1,348 | 1,621 | $236,507 | $123,422 |
| 2021 | 18 | 1,490 | 1,861 | $209,808 | $134,231 |
| 2020 | 20 | 1,676 | 2,071 | $232,929 | $135,013 |
All Medicare Procedures & Services
70 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 308 | 489 | $95,844 | $38,372 | 40.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 269 | 269 | $53,800 | $34,749 | 64.6% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 205 | 206 | $26,162 | $15,787 | 60.3% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 24 | 24 | $9,000 | $6,751 | 75.0% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 53 | 53 | $4,081 | $3,812 | 93.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 58 | 66 | $9,108 | $3,318 | 36.4% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 47 | 54 | $7,506 | $2,960 | 39.4% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 17 | 17 | $4,318 | $2,812 | 65.1% |
| 99441 | Telephone medical discussion with physician, 5-10 minutes | Office | 2023 | 56 | 65 | $5,525 | $2,153 | 39.0% |
| G0296 | Counseling visit to discuss need for lung cancer screening using low dose ct scan (ldct) (service is for eligibility determination and shared decision making) | Office | 2023 | 71 | 71 | $2,911 | $2,003 | 68.8% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 12 | 13 | $4,043 | $1,957 | 48.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 58 | 58 | $1,450 | $1,397 | 96.3% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 24 | 24 | $600.00 | $588.00 | 98.0% |
| 99406 | Smoking and tobacco use intensive counseling, 4-10 minutes | Office | 2023 | 22 | 23 | $460.00 | $339.71 | 73.9% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 18 | 19 | $358.00 | $180.88 | 50.5% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 12 | 12 | $432.00 | $115.30 | 26.7% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 11 | 11 | $55.00 | $53.90 | 98.0% |
| G0403 | Electrocardiogram, routine ecg with 12 leads; performed as a screening for the initial preventive physical examination with interpretation and report | Office | 2023 | 11 | 11 | $319.00 | $46.12 | 14.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 325 | 514 | $100,744 | $41,461 | 41.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 285 | 285 | $57,000 | $37,793 | 66.3% |
| 99497 | Advance care planning, first 30 minutes | Office | 2022 | 176 | 176 | $22,352 | $14,515 | 64.9% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 110 | 141 | $19,599 | $7,640 | 39.0% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 74 | 75 | $5,025 | $4,920 | 97.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 56 | 72 | $9,936 | $4,227 | 42.5% |
| 99441 | Telephone medical discussion with physician, 5-10 minutes | Office | 2022 | 92 | 122 | $10,370 | $4,139 | 39.9% |
About Dr. Ngoc Le, D.O
Dr. Ngoc Le, D.O is a Family Medicine healthcare provider based in Verona, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/01/2006. The National Provider Identifier (NPI) number assigned to this provider is 1629045588.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ngoc Le, D.O has received a total of $2,670 in payments from pharmaceutical and medical device companies, with $43.65 received in 2024. These payments were reported across 164 transactions from 19 companies. The most common payment nature is "Food and Beverage" ($2,622).
As a Medicare-enrolled provider, Le has provided services to 5,790 Medicare beneficiaries, totaling 7,038 services with total Medicare billing of $510,060. Data is available for 4 years (2020–2023), covering 70 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Other Specialties Family Medicine
- Location Verona, VA
- Active Since 03/01/2006
- Last Updated 11/10/2023
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1629045588
Products in Payments
- Ozempic (Drug) $371.15
- TRULICITY (Drug) $314.81
- FARXIGA (Drug) $303.09
- XARELTO (Drug) $212.28
- Vascepa (Drug) $200.40
- CHANTIX (Drug) $140.75
- TOUJEO (Drug) $131.34
- BREO (Drug) $85.24
- PREVNAR - 13 (Biological) $82.61
- ELIQUIS (Drug) $62.41
- Victoza (Drug) $61.40
- JANUVIA (Drug) $54.92
- INVOKANA (Drug) $44.11
- SYMBICORT (Drug) $41.34
- PREVNAR 13 (Biological) $39.94
- PNEUMOVAX 23 (Biological) $37.40
- ADVAIR (Drug) $36.60
- Amitiza (Drug) $35.63
- SOLIQUA 100/33 (Drug) $34.53
- EMGALITY (Drug) $33.25
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Verona
Dr. Sally Mravcak, M.d, M.D
Family Medicine — Payments: $53,728
Everett Schlam, Md, MD
Family Medicine — Payments: $1,913
Keith Marshall, Md, MD
Family Medicine — Payments: $1,840
Dr. Valery Vera-Connolly, M.d, M.D
Family Medicine — Payments: $1,680
Dr. Kennedy Daftani, M.d, Mhsa, M.D, MHSA
Family Medicine — Payments: $942.18
Mrs. Diane Landauer, M.d, M.D
Family Medicine — Payments: $879.22